A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer

Clinical trial NCT04619797 · COMPLETED

Trial details

NCT number: NCT04619797
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2020-12-15
Primary completion: 2024-04-19
Enrollment: 542

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.